Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Subconjunctival IVIg (Gamunex-C) Injection for Corneal Neovascularization and Inflammatory Conditions

NCT02042027 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT02042027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02042027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Subconjunctival IVIg (Gamunex-C) Injection for Corneal Neovascularization and Inflammatory Conditions
Lead sponsor
University of Utah
Phase
Phase 1
Overall status
Withdrawn
Start date
July 31, 2014
Completion date
July 31, 2016
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anterior segment inflammation, corneal graft failure, corneal neovascularization